Table 1.
Relationship between MNX1 Expression and Clinicopathological Features of Breast Cancer Patients
| Clinicopathological Parameters |
MNX1 Expression |
OR | p Value | |
|---|---|---|---|---|
| High (30) | Low (30) | |||
| Age (Years) | ||||
| 55 | 14 | 10 | 1.750 |
0.292 |
| ≤55 |
16 |
20 |
||
| Menopause Status | ||||
| Postmenopausal | 22 | 14 | 3.143 |
0.035∗ |
| Premenopausal |
8 |
16 |
||
| Tumor Size | ||||
| >2 cm | 18 | 13 | 1.962 |
0.196 |
| ≤2 cm |
12 |
17 |
||
| Lymph Node Metastasis | ||||
| Positive | 21 | 16 | 2.042 |
0.184 |
| Negative |
9 |
14 |
||
| TNM Stage | ||||
| III–IV | 6 | 3 | 2.250 |
0.278 |
| I–II |
24 |
27 |
||
| ER Status | ||||
| Positive | 20 | 22 | 0.727 |
0.573 |
| Negative |
10 |
8 |
||
| PR Status | ||||
| Positive | 17 | 19 | 0.757 |
0.598 |
| Negative |
13 |
11 |
||
| Her2 Status | ||||
| Positive | 16 | 7 | 3.755 |
0.017∗ |
| Negative |
14 |
23 |
||
| Ki67 | ||||
| >14% | 25 | 24 | 1.250 | 0.739 |
| ≤14% | 5 | 6 | ||
OR, odds ratio.
∗
p < 0.05.